Your browser doesn't support javascript.
loading
Attention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period.
Bang Madsen, Kathrine; Bliddal, Mette; Skoglund, Charlotte Borg; Larsson, Henrik; Munk-Olsen, Trine; Madsen, Malene Galle; Hove Thomsen, Per; Bergink, Veerle; Srinivas, Chaitra; Cohen, Jacqueline M; Brikell, Isabell; Liu, Xiaoqin.
Afiliação
  • Bang Madsen K; School of Business and Social Sciences, NCRR - National Centre for Register-based Research, Aarhus University, Fuglesangs Allé 26, Building R, 8210, Aarhus V, Denmark. kbang.ncrr@au.dk.
  • Bliddal M; CIRRAU - Centre for Integrated Register-based Research, Aarhus University, Aarhus, Denmark. kbang.ncrr@au.dk.
  • Skoglund CB; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Larsson H; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
  • Munk-Olsen T; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Madsen MG; School of Medical Sciences, Örebro University, Örebro, Sweden.
  • Hove Thomsen P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Bergink V; School of Business and Social Sciences, NCRR - National Centre for Register-based Research, Aarhus University, Fuglesangs Allé 26, Building R, 8210, Aarhus V, Denmark.
  • Srinivas C; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Cohen JM; School of Business and Social Sciences, NCRR - National Centre for Register-based Research, Aarhus University, Fuglesangs Allé 26, Building R, 8210, Aarhus V, Denmark.
  • Brikell I; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Liu X; Research Center at the Department for Child and Adolescent Psychiatry, Aarhus University Hospital, Skejby, Denmark.
CNS Drugs ; 38(4): 303-314, 2024 04.
Article em En | MEDLINE | ID: mdl-38489019
ABSTRACT

BACKGROUND:

An increasing number of women of reproductive age are treated with attention-deficit hyperactivity disorder (ADHD) medication; however, patterns of ADHD medication use for women in the perinatal period have not been well described.

OBJECTIVE:

This study aimed to describe ADHD medication use patterns from 1 year before pregnancy to 1 year after delivery, and to describe sociodemographic characteristics and clinical features by medication trajectories.

METHODS:

The population-based cohort study included pregnancies in Denmark between 1997 and 2020, from the Medical Birth Register, by women who filled at least one prescription for ADHD medication from 12 months before pregnancy until 12 months after delivery. We applied group-based trajectory modeling to classify women into subgroups based on the identification of heterogeneous ADHD medication treatment patterns, and described the characteristics associated with these groups.

RESULTS:

Overall, we included 4717 pregnancies leading to liveborn singletons by 4052 mothers with a mean (standard deviation) age of 27.5 (5.6) years. We identified four treatment trajectories across pregnancy and the postpartum period continuers (23.3%), discontinuers (41.8%), interrupters who ceased filling prescriptions during pregnancy but resumed postpartum (17.2%), and postpartum initiators (17.7%). Continuers were older at the time of conception, gave birth in more recent years, were more likely to smoke during pregnancy, and used other psychotropic medications during pregnancy. A large proportion of continuers used methylphenidate (89.1%) compared with the other groups (75.9-84.1%) and had switched ADHD medication type during the whole period (16.4% vs. 7.4-14.8%).

CONCLUSION:

We found that approximately 60% of women discontinued or interrupted their ADHD medication around pregnancy, and those who continued differed in sociodemographic and clinical factors that may reflect more severe ADHD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Estimulantes do Sistema Nervoso Central / Metilfenidato Limite: Adult / Female / Humans / Pregnancy Idioma: En Revista: CNS Drugs / CNS drugs Assunto da revista: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Estimulantes do Sistema Nervoso Central / Metilfenidato Limite: Adult / Female / Humans / Pregnancy Idioma: En Revista: CNS Drugs / CNS drugs Assunto da revista: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Dinamarca